Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
+$588M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Illumina
ILMN
|
+$398M |
| 4 |
argenx
ARGX
|
+$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$600M |
| 2 |
AbbVie
ABBV
|
+$323M |
| 3 |
Sherwin-Williams
SHW
|
+$309M |
| 4 |
Atlassian
TEAM
|
+$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Barrett Business Services
BBSI
$1.22B
| $287K | ﹤0.01% |
+12,948
| New | +$287K |
|
2302
BioLife Solutions
BLFS
$1.26B
| $286K | ﹤0.01% |
+13,173
| New | +$286K |
|
2303
Planet Labs
PL
$2.74B
| $286K | ﹤0.01% |
72,855
+39,292
| +117% | +$154K |
|
2304
WIX.com
WIX
$9.3B
| $285K | ﹤0.01% |
2,853
-400,407
| -99% | -$40M |
|
2305
Bally's
BALY
$482M
| $281K | ﹤0.01% |
+14,424
| New | +$281K |
|
2306
National Research Corp
NRC
$363M
| $281K | ﹤0.01% |
6,473
-24,932
| -79% | -$1.08M |
|
|
ACRE
2307
Ares Commercial Real Estate
ACRE
$271M
| $281K | ﹤0.01% |
+30,965
| New | +$281K |
|
2308
Kanzhun
BZ
$11.1B
| $281K | ﹤0.01% |
14,777
-141
| -0.9% | -$2.68K |
|
|
CFB
2309
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $281K | ﹤0.01% |
+26,873
| New | +$281K |
|
2310
F&G Annuities & Life
FG
$4.69B
| $281K | ﹤0.01% |
+15,490
| New | +$281K |
|
2311
Eventbrite
EB
$264M
| $279K | ﹤0.01% |
32,527
+19,264
| +145% | +$165K |
|
|
EFC
2312
Ellington Financial
EFC
$1.37B
| $278K | ﹤0.01% |
+22,786
| New | +$278K |
|
2313
Trustco Bank Corp NY
TRST
$745M
| $277K | ﹤0.01% |
+8,691
| New | +$277K |
|
2314
Anavex Life Sciences
AVXL
$881M
| $277K | ﹤0.01% |
32,290
+18,720
| +138% | +$161K |
|
2315
Smith & Wesson
SWBI
$390M
| $277K | ﹤0.01% |
22,482
+11,181
| +99% | +$138K |
|
2316
Vital Energy
VTLE
$609M
| $277K | ﹤0.01% |
+6,079
| New | +$277K |
|
2317
Peoples Bancorp
PEBO
$1.11B
| $276K | ﹤0.01% |
+10,722
| New | +$276K |
|
2318
OrthoPediatrics
KIDS
$524M
| $275K | ﹤0.01% |
+6,223
| New | +$275K |
|
|
CIR
2319
DELISTED
CIRCOR International, Inc
CIR
| $275K | ﹤0.01% |
+8,834
| New | +$275K |
|
2320
Enact Holdings
ACT
$5.72B
| $275K | ﹤0.01% |
+12,014
| New | +$275K |
|
2321
Dorian LPG
LPG
$1.35B
| $273K | ﹤0.01% |
+13,696
| New | +$273K |
|
2322
Argan
AGX
$2.82B
| $273K | ﹤0.01% |
+6,742
| New | +$273K |
|
2323
Leonardo DRS
DRS
$10.9B
| $272K | ﹤0.01% |
+20,922
| New | +$272K |
|
2324
Theravance Biopharma
TBPH
$701M
| $272K | ﹤0.01% |
25,043
+14,055
| +128% | +$152K |
|
2325
GoPro
GPRO
$264M
| $271K | ﹤0.01% |
53,988
+30,247
| +127% | +$152K |
|